Briggs & Stratton (NYSE: BGG ) is expected to report Q1 earnings around Oct. 17. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Briggs & Stratton's revenues will drop -20.1% and EPS will remain in the red.
The average estimate for revenue is $317.6 million. On the bottom line, the average EPS estimate is -$0.18.
Last quarter, Briggs & Stratton booked revenue of $501.2 million. GAAP reported sales were 17% lower than the prior-year quarter's $605.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.22. GAAP EPS were -$0.18 for Q4 against -$0.36 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 18.9%, 100 basis points better than the prior-year quarter. Operating margin was 3.8%, 10 basis points worse than the prior-year quarter. Net margin was -1.7%, 120 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $2.00 billion. The average EPS estimate is $1.36.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 89 members out of 120 rating the stock outperform, and 31 members rating it underperform. Among 39 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 28 give Briggs & Stratton a green thumbs-up, and 11 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Briggs & Stratton is outperform, with an average price target of $22.00.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Briggs & Stratton. Learn how to maximize your investment income and get "The 3 DOW Stocks Dividend Investors Need." Click here for instant access to this free report.
- Add Briggs & Stratton to My Watchlist.